Literature DB >> 10230764

Possible mechanisms of paclitaxel-induced apoptosis.

W Fan1.   

Abstract

Paclitaxel, a naturally occurring antimicrotubule agent, has been demonstrated to possess significant cell-killing activity in a variety of tumor cells through induction of apoptosis. It is currently unclear whether this finding suggests a novel mechanism of action for paclitaxel against tumor cells or just represents an end product of the well-known action of paclitaxel on microtubules and cell cycle arrest. Morphologically, a sustained block of mitosis seems to be required for paclitaxel-induced apoptosis because most apoptotic events are observed to occur in cells showing a prior mitotic arrest. However, this morphological correlation alone does not prove that paclitaxel-induced apoptosis is indeed a secondary event resulting from mitotic arrest. Instead, several lines of evidence obtained from recent studies have suggested that apoptotic cell death induced by paclitaxel may occur via a signaling pathway independent of microtubules and G2/M arrest.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10230764     DOI: 10.1016/s0006-2952(99)00006-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  22 in total

1.  Antiproliferative cardenolides from Pentopetia androsaemifolia Decne. from the Madagascar rain forest.

Authors:  Eba Adou; James S Miller; Fidisoa Ratovoson; Chris Birkinshaw; Rabodo Andriantsiferana; Vincent E Rasamison; David G I Kingston
Journal:  Indian J Exp Biol       Date:  2010-03       Impact factor: 0.818

2.  Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.

Authors:  Jan Kovár; Marie Ehrlichová; Barbora Smejkalová; Ilaria Zanardi; Iwao Ojima; Ivan Gut
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

3.  G2 checkpoint abrogator abates the antagonistic interaction between antimicrotubule drugs and radiation therapy.

Authors:  Meihua Sui; Hongfang Zhang; Xiaoyun Di; Jinjia Chang; Youqing Shen; Weimin Fan
Journal:  Radiother Oncol       Date:  2012-06-09       Impact factor: 6.280

4.  Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells.

Authors:  Jana Vobořilová; Vlasta Němcová-Fürstová; Jitka Neubauerová; Iwao Ojima; Ilaria Zanardi; Ivan Gut; Jan Kovář
Journal:  Invest New Drugs       Date:  2009-12-16       Impact factor: 3.850

5.  Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants.

Authors:  Radka Václavíková; Stanislav Horský; Petr Simek; Ivan Gut
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-08-14       Impact factor: 3.000

Review 6.  Recent advances of cocktail chemotherapy by combination drug delivery systems.

Authors:  Quanyin Hu; Wujin Sun; Chao Wang; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2015-11-06       Impact factor: 15.470

7.  Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.

Authors:  Chun-Fang Zou; Luoqi Jia; Hongyan Jin; Ming Yao; Naiqing Zhao; Jin Huan; Zhen Lu; Robert C Bast; Youji Feng; Yinhua Yu
Journal:  BMC Cancer       Date:  2011-01-19       Impact factor: 4.430

8.  Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.

Authors:  Anna Felisiak-Golabek; Alina Rembiszewska; Iwona K Rzepecka; Lukasz Szafron; Radoslaw Madry; Magdalena Murawska; Tomasz Napiorkowski; Piotr Sobiczewski; Beata Osuch; Jolanta Kupryjanczyk
Journal:  J Ovarian Res       Date:  2011-11-10       Impact factor: 4.234

9.  Caspase-2 is involved in cell death induction by taxanes in breast cancer cells.

Authors:  Michael Jelínek; Kamila Balušíková; Dana Kopperová; Vlasta Nĕmcová-Fürstová; Jan Šrámek; Julie Fidlerová; Ilaria Zanardi; Iwao Ojima; Jan Kovář
Journal:  Cancer Cell Int       Date:  2013-05-15       Impact factor: 5.722

10.  The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.

Authors:  Moltira Promkan; Sumana Dakeng; Subhas Chakrabarty; Oliver Bögler; Pimpicha Patmasiriwat
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.